| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―19 |
SARS-CoV-2 Omicron EG.5 and JN.1 induce enhanced pathogenicity in K18-hACE2 mice compared with the early Omicron subvariants |
Mandy Tsoi Man Ho, Nigeer Te, Kenrie Pui Yan Hui, Rachel Hiu Ha Ching, John Chi Wang Ho, Samuel Mo Sheung Cheng, et al. (+4) John Malcolm Nicholls, Michael Chi Wai Chan, Leo Lit Man Poon, Alex Wing Hong Chin |
| 2 |
[GO] |
2025―Aug―25 |
Long-term impact of SARS-CoV-2 infection in hamsters |
Alexandra Le Bras |
| 3 |
[GO] |
2025―Mar―04 |
Pig model to study COVID-19 disease |
Alexandra Le Bras |
| 4 |
[GO] |
2024―Nov―26 |
COVID-19 affects vitamin D metabolism in the kidney |
Jorge Ferreira |
| 5 |
[GO] |
2023―Aug―29 |
New insights into SARS-CoV-2 brain infection and olfactory impairment in the hamster model |
Jorge Ferreira |
| 6 |
[GO] |
2023―Aug―29 |
A new fly resource to study SARS-CoV-2 infection |
Alexandra Le Bras |
| 7 |
[GO] |
2023―Aug―29 |
Genetically diverse mice to model variable responses to SARS-CoV-2 infection |
Alexandra Le Bras |
| 8 |
[GO] |
2023―Jun―29 |
A mouse model of SARS-CoV-2 transmission |
Jorge Ferreira |
| 9 |
[GO] |
2022―Oct―25 |
APOE genotype linked to COVID-19 severity |
Alexandra Le Bras |
| 10 |
[GO] |
2022―Apr―19 |
Targeting the eicosanoid pathway treats COVID-19 in middle-aged mice |
Ioannis Bakoyiannis |
| 11 |
[GO] |
2022―Mar―03 |
Cardiovascular effects of SARS-CoV-2 in hamster |
Ioannis Bakoyiannis |
| 12 |
[GO] |
2022―Feb―02 |
Humanized mice for COVID-19 research |
Alexandra Le Bras |
| 13 |
[GO] |
2021―Dec―23 |
A new lethal mouse-adapted SARS-CoV-2 for COVID research |
Alexandra Le Bras |
| 14 |
[GO] |
2021―Oct―25 |
Monitoring SARS-CoV-2 infection with reporter viruses |
Alexandra Le Bras |
| 15 |
[GO] |
2021―Sep―30 |
The impact of COVID-19 lockdowns on the genetic integrity of your mouse colonies |
Natalia Moncaut, Sarah Hart-Johnson |
| 16 |
[GO] |
2021―Jun―29 |
Oh dear, SARS-CoV-2 in deer mice |
Ellen P. Neff |
| 17 |
[GO] |
2021―Jun―23 |
Nonhuman primate models for SARS-CoV-2 Research: Managing demand for specific-pathogen-free (SPF) animals |
Miguel A. Contreras, Matthew E. Arnegard, Michael C. Chang, Sheri Hild, Franziska Grieder, Stephanie J. Murphy |
| 18 |
[GO] |
2021―May―24 |
Nonhuman primate models for SARS-CoV-2 research: Cryopreservation as a means to maintain critical models and enhance the genetic diversity of colonies |
Matthew E. Arnegard, Sheri Ann Hild |
| 19 |
[GO] |
2021―Apr―29 |
Nonhuman primate models for SARS-CoV-2 research: Infrastructure needs for pandemic preparedness |
Sheri Ann Hild, Michael C. Chang, Stephanie J. Murphy, Franziska B. Grieder |
| 20 |
[GO] |
2021―Apr―21 |
Meeting the need for COVID-19 models |
Ellen P. Neff |
| 21 |
[GO] |
2021―Mar―30 |
Nonhuman primate models for SARS-CoV-2 research: Consider alternatives to macaques |
Michael C. Chang, Sheri Hild, Franziska Grieder |
| 22 |
[GO] |
2021―Jan―27 |
More monkey models for studying COVID-19 |
Ellen P. Neff |
| 23 |
[GO] |
2020―Jul―20 |
Syrian hamsters as a small animal model for COVID-19 research |
Alexandra Le Bras |
| 24 |
[GO] |
2020―Jun―15 |
Modeling SARS-CoV-2 infection in mice |
Alexandra Le Bras |
| 25 |
[GO] |
2020―May―18 |
SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques |
Alexandra Le Bras |
| 26 |
[GO] |
2020―May―12 |
Possible challenges in behavioral phenotyping of rodents following COVID-19 lockdown |
Kailash Manda |
| 27 |
[GO] |
2020―May―12 |
Mobilizing animal models against a pandemic |
Michael Eisenstein |
| 28 |
[GO] |
2020―Apr―20 |
COVID-19 Q&A: Animal care continues |
Ellen P. Neff |
| 29 |
[GO] |
2020―Apr―20 |
COVID-19 Q&A: Keeping a cancer core going |
Ellen P. Neff |
| 30 |
[GO] |
2020―Apr―15 |
COVID-19 Q&A: A fish facility down to its core |
Ellen P. Neff |
| 31 |
[GO] |
2020―Apr―15 |
COVID-19 Q&A: Collaborating and coordinating keeps a zebrafish facility going |
Ellen P. Neff |
| 32 |
[GO] |
2020―Apr―13 |
Efficacy of remdesivir in a rhesus macaque model of MERS-CoV infection |
Alexandra Le Bras |
| 33 |
[GO] |
2020―Apr―06 |
A Word from OLAW: COVID-19 guidance |
Patricia Brown |
